Site Map

Home
About Ph+ CML-CP
- Understanding Ph+ CML in Chronic Phase
- Understanding the T315I Mutation in Ph+ CML-CP
- Treatment Challenges
About SCEMBLIX
- What Is SCEMBLIX?
- SCEMBLIX for Ph+ CML-CP with T315I Mutation
- Taking SCEMBLIX
- Blood Testing and SCEMBLIX
Side Effects
- Common and Serious Side Effects of SCEMBLIX
Patient Support

Important Safety Information

Before taking SCEMBLIX, tell your doctor about all your medical conditions, including if you:

have a history of inflammation of your pancreas (pancreatitis)
have a history of heart problems or blood clots in your arteries and veins (types of blood vessels)
are pregnant or plan to become pregnant. SCEMBLIX can harm your unborn baby ...

Approved Uses

SCEMBLIX is a prescription medicine used to treat adults with:

Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with 2 or more tyrosine kinase inhibitors (TKIs)
Ph+ CML in CP with the T315I mutation ...

Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USES